期刊文献+

2型糖尿病合并早期肾病患者与心血管疾病危险因素的关系研究 被引量:3

The Relationship Research of Patients with Type 2 Diabetes Mellitus with Early Nephropathy and Cardiovascular Disease Risk Factors
暂未订购
导出
摘要 目的探讨2型糖尿病合并早期肾病患者微量清蛋白尿的患病率及其与心血管疾病危险因素的关系。方法以2009年3月—2011年3月住院的130例2型糖尿病患者为研究对象,将患者分为两组:合并微量清蛋白尿者为A组,未合并微量清蛋白尿者为B组。对两组患者的左心室质量指数(left ventricular mass index,LVMI)、体质指数(body mass index,BMI)、糖化血红蛋白(HbA1c)、血脂和颈动脉内膜中层厚度(intima-media thickness,IMT)进行测定。结果 130例患者中微量清蛋白尿的患病率为32.3%,其中男女患病率比较,差异无统计学意义(P>0.05)。A、B两组患者年龄、糖尿病病程、血压、LVMI、HbA1c、平均IMT比较,差异均有统计学意义(P<0.05)。结论 2型糖尿病合并微量清蛋白尿患者的LVMI、IMT、BMI、糖尿病病程明显高于尿蛋白阴性患者,医务人员对糖尿病肾病早筛查早干预可预防心血管疾病的发生。 Objective To discuss the relationship between the prevalence of type 2 diabetes with early nephropathy patients with microalbuminuria and factors and risk of cardiovascular disease.Methods In March 2009 to March 2011,130 patients with type 2 diabetes hospitalized as the object of study,the patients were divided into two groups:combined with microalbuminuria as A group and no complicated with microalbuminuria to group B.On left ventricular mass index of the patients in the two groups(left ventricular mass index,LVMI),body mass index(BMI),glycosylated hemoglobin(HbA1c),blood lipid and carotid artery intima-media thickness(IMT) were measured.Results 130 patients with microalbuminuria prevalence rate was 32.3%,the rate in male and female,the difference was not statistically significant(P〈0.05).A,B two groups of patients with age,duration of diabetes,LVMI,HbA1c,average IMT,the differences were statistically significant(P〈0.05).Conclusion Type 2 diabetic patients with microalbuminuria were LVMI,IMT,BMI,duration of diabetes was significantly higher than that of urine protein negative patients,medical staff on diabetic nephropathy early screening early intervention can prevent the occurrence of cardiovascular disease.
出处 《实用心脑肺血管病杂志》 2013年第6期14-15,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金 河北省科技厅科技支撑计划项目(12277779)
关键词 微量清蛋白尿 糖尿病 2型 心血管疾病 危险因素 Microalbuminuria Diabetes mellitus type 2 Cardiovascular diseases Risk fator
  • 相关文献

参考文献10

  • 1American Diabetes Assocation. Screening for type 2 diabetes [ J]. Dia- betes Care, 2000, 23 (Suppl) : $20-$23.
  • 2Boronat M, Varillas VF, Saavedra P, et al. Diabetes meUitus and im- paired glucose regulation in the Canary Islands (Spain) : prevalence andassociated factors in the adult population of Telde, Gran Canaria E J]. Diabet Med, 2006, 23: 148-155.
  • 3American Diabetes Assocation. Cardiovascular risk factors and disease management in type 2 diabetes with diabetic nephropathy [J]. Diabetes Care, 2006, 29 : 498 - 503.
  • 4Ruggenenti P, Remazzi G. Nephropathy of type -2 diabetes mellitus [J]. J Am Soc 1%phrol, 1998, 9: 2157-2169.
  • 5Keller CK, Bergis KH, Fliser D, et 81. Renal findings in patients with short - term type 2 diabetes [ J]. J Am Soc Nephrol, 1996, 12 : 2627 - 2635.
  • 6Dries DL, Sweitzer NK, Drazner MH, et 8]. Prognostic impact of dia- betes roeUitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction [J]. J Am Coil Cardiol, 2001, 38: 421 - 428.
  • 7张静梅,康丽娜,李佩文.2型糖尿病肾病患者心血管疾病危险因素分析[J].江苏医药,2011,37(2):182-184. 被引量:14
  • 8Gnerci B, B6hme P, Kearney - Schwa:'tz A, et 81. Endothelial dys- function and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus [ J]. Diabetes Metab 2001, 27 (4Ptl): 436 -447.
  • 9李莉,张爱军,汪文莉.血尿酸干预对2型糖尿病早期肾病患者胱抑素C及尿微量清蛋白排泄率的影响[J].实用心脑肺血管病杂志,2012,20(8):1303-1304. 被引量:11
  • 10陈永斌,万永富.芪参益气滴丸治疗2型糖尿病早期肾病的疗效研究[J].中国全科医学,2011,14(5):520-522. 被引量:7

二级参考文献17

  • 1喻红.自拟降糖方治疗糖尿病肾病疗效分析[J].中国全科医学,2009,12(6):507-509. 被引量:3
  • 2王颜刚,苗志敏,闫胜利,李长贵.高尿酸血症及痛风病人血尿酸与胰岛素抵抗的关系[J].青岛大学医学院学报,2004,40(3):197-199. 被引量:34
  • 3王生余,曾彩虹,刘志红.血清胱抑素C——评价肾功能的新指标[J].肾脏病与透析肾移植杂志,2006,15(4):366-370. 被引量:40
  • 4廖晓琴,刘云.依那普利对糖尿病早期肾病的防治效果分析[J].高校保健医学研究与实践,2007,4(1):39-40. 被引量:4
  • 5邱晓堂,张永杰,吴中虎,霍娟勇,高伟铿,王巧凡.滋脾通络汤治疗糖尿病早期肾病临床观察[J].中华中医药学刊,2007,25(6):1169-1171. 被引量:8
  • 6Brancati FL,Whelton PK, Randall BL,et aL Risk of end-stage renal disease in diabetes mellitus:a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial[J]. JAMA, 1997,278 (23) : 2069-2074.
  • 7Levey AS, Gassman J J, Hall PM, et al. Assessing the progression of renal disease in elinieal studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group[J]. J Am Soe Nephrol, 1991,1 (19) : 1087-1094.
  • 8National Kidney Foundation: K/DOQI clinical practice guideline5 for throttle kidney disease: evaluation, classification and stratification: Guideline 4: Estimation of GFR [J]. Am J Kid Dis, 2002,39 (Suppl 1) : S83-S86.
  • 9Allan PL, Mowbray PI, Lee AJ, et al. Relationship between carotid intima-media thickness and symptomatic and asymptomarie peripheral arterial diseas. The Edinburgh Artery Study [J]. Stroke, 1997,28(2) : 348-353.
  • 10Holaj R, Spaeil J, Petrasek J, et al. Intima-media thickness of the common carotid artery is the significant predictor of angio- graphically proven coronary artery disease[J]. Can J Cardiol, 2003,19(6) :670-676.

共引文献26

同被引文献56

  • 1覃绍鹏,黄锦雄,韦秀英.糖尿病性肾病患者凝血-抗凝活性的研究[J].血栓与止血学,2006,12(2):67-69. 被引量:4
  • 2孙忠实,朱珠,肖燕萍.抗血小板药物的合理应用(一)[J].中国药物警戒,2007,4(4):240-244. 被引量:8
  • 3Sacks FM, Hermans MP, Fioretto P, et al. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries[J]. Circulation, 2014, 4, 129(9): 999-1008.
  • 4Abd-Allha E, Hassan BB, Abduo M, et al. Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus[J]. Indian J Endocrinol Metab, 2014,18(1): 94-98.
  • 5Figueira MF, Monnerat-Cahli G, Medei E, et al. MicroRNAs: potential therapeutic targets in diabetic complications of the cardiovascular and renal systems[J]. Acta Physiol (Oxf), 2014, 211(3): 491-500.
  • 6Masaaki T, Nakayama P, Toshinobu R, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study[J]. Hypertension research: official journal of the Japanese Society ofHypertsion, 2011, 34(10): 1106-1110.
  • 7Buraczynska M, Zukowski P, Ksiazek P, et al. Transcription factor 7-like 2 (TCF7L2) 'gene polymorphism and clinical phenotype in end-stage renal disease patients[J]. Mol Bioi Rep, 2014, 41(6): 4063- 4068.
  • 8Nakamura M, Sasai N, Hisatome I, et al. Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes[J]. Clin Pharmacol, 2014, 3, 6: 79-86.
  • 9Yamout H, Lazich I, Bakris GL. Blood pressure, hypertension, RAAS blockade; and drug therapy in diabetic kidney disease[J]. Adv Chronic Kidney Dis, 2014, 21(3): 281-286.
  • 10Pa Isson R, Patel UD. Cardiovascular complications of diabetic kidney disease[J]. Adv Chronic Kidney Dis, 2014, 21(3): 273-280.

引证文献3

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部